
æ°ããŒã¿ã«ããã°ãã»ãšãã©ã®ã«ãã人ã¯COVIDã®äºé²æ¥çš®ãæ¬é ããŠãã
å èšäºã¯ãã¡ããã/Click here to read the original article.
é£éŠæ¿åºã®ããŒã¿ã«ãããšããXBB.1.5ã¯ã¯ãã³ãã®COVIDããŒã¹ã¿ãŒãæ¥çš®ããã«ãã人ã¯ããã14.6ïŒ ã«éããªãã
ãªã¿ã¯ïŒLifeSiteNewsïŒ - 泚å°ã倧ã çã«å®£äŒããŠããé£éŠæ¿åºã®ææ°æ å ±ã«ãããšãã«ãã人ã®å€§å€æ°ã¯COVIDã®è£å©æ³šå°ãçã£åããæåŠããŠããã
é£éŠæ¿åºã®COVID-19äºé²æ¥çš®ã®ããŒã¿ïŒ ã¯ã¯ãã³æ¥çš®çããã·ã¥ããŒãã«ãããšããXBB.1.5ã¯ã¯ãã³ãCOVIDããŒã¹ã¿ãŒãæ¥çš®ããã«ãã人ã¯14.6ïŒ ãçŽ570äžäººã«éããªãã
60æ³æªæºã§ã¯ãCOVIDããŒã¹ã¿ãŒãåããããšãããã®ã¯3åã®1以äžã§ããã70æ³ä»¥äžã§ã¯ã44ïŒ ãCOVIDã®è¿œå æ¥çš®ãåããŠããã
80æ³ä»¥äžã®ã«ãã人ã«è³ã£ãŠã¯ã52ïŒ ãCOVIDããŒã¹ã¿ãŒãæ¬é ããŠããã
0ïœ4æ³ã®ã«ããŽãªãŒã§ã¯ãCOVIDããŒã¹ã¿ãŒãåããããšãããã®ã¯ããã3.5ïŒ ã§ããã12ïœ17æ³ã®ã«ããäººã®æ¥çš®çã¯4.6ïŒ ã§ã18ïœ29æ³ã§ã¯3.7ïŒ ã«äœäžããŠããã
30ïœ39æ³ã®ã«ããäººã®æ¥çš®çã¯6.9ïŒ ã§ã40ïœ49æ³ã¯8.9ïŒ ã§ããã50ïœ59æ³ã®æ¥çš®çã¯13.5ïŒ ã§ã60ïœ69æ³ã§ã¯28.1ïŒ ã«ãªãã
COVIDããŒã¹ã¿ãŒã®æåçã¯ãç·æ§ã®13.3ïŒ ã女æ§ã®15.8ïŒ ãäžåã£ãŠããã
ãã®ããŒã¿ã¯2023幎12æ8æ¥çŸåšã®ãã®ã§ããã
ã«ããã®COVIDããŒã¹ã¿ãŒæ¥çš®çãäœãã®ã¯ããžã£ã¹ãã£ã³ã»ãã«ããŒéŠçžçããé£éŠæ¿åºã2020幎åŸåã«ãã¡ã€ã¶ãŒç€Ÿãšå¥çŽãçµãã éããã®äºé²æ¥çš®ã«ã¯æªç¥ã®ãªã¹ã¯ã䌎ãå¯èœæ§ãããããšãç¥ã£ãŠãããšããå ±éã圱é¿ããŠããå¯èœæ§ãããã
ãã«ããŒæ¿æš©ã¯ä¿å¥çã®ååãåŸãŠãCOVIDãžã£ãã倧ã çã«å®£äŒããããã«ããŒæ¿åºã¯ãä¿å¥çã®ååãåŸãŠãæ¥éœçºå£²ãããCOVIDãžã£ãã倧ã çã«å®£äŒããã
11æãã©ã€ããµã€ãã»ãã¥ãŒã¹ã¯ãæè¿å ¬è¡šãããé£éŠæ¿åºãšãã¡ã€ã¶ãŒç€Ÿãšã®COVID-19ã¯ã¯ãã³å¥çŽïŒmRNAã«åºã¥ãå®éšç泚å°ã®æ°çŸäžååïŒãããã®æ³šå°ã®é·æçå®å šæ§ãšæå¹æ§ãæªç¥ã§ããããšãæ¿åºãåãå ¥ããããšã«åæããããšã瀺ããŠããããšå ±ããã
æ¿åºã¯ãCOVID泚å°ãšãã®ææããCOVID-19ãã³ãããã¯ã®ç·æ¥äºæ ã®ããã«æ¥éã«éçºãããããã®ã§ããããã®å±éåŸã«ããã«ç ç©¶ãããããšãå¥çŽã«çœ²åããããšã§èªããªããã°ãªããªãã£ãã
LifeSiteNewsã¯å æãããé£éŠè°å¡ãã«ããä¿å¥çã«å¯Ÿãããã¡ã€ã¶ãŒã»ãã€ãªã³ããã¯ç€Ÿã®ææ°ã®COVID泚å°ãæ¿èªãããåŸããã®æå¹æ§ãšå®å šæ§ã瀺ãèšåºããŒã¿ããããã©ãããå°ãããšãããã«ããä¿å¥çã«ã¯ãã®ãããªããŒã¿ããªãããšãæããã«ãªã£ããšå ±ããã
ã«ããä¿å¥çã¯2023幎9æãmoderna mRNAããŒã¹ã®COVID泚å°ãæ¿èªãããã®åŸãã¡ã€ã¶ãŒã»ãã€ãªã¢ã³ããã¯ã®COVID泚å°ãæ¿èªãããããã®æ³šå°ãåãã35人ã«1人ãå¿çé害ãèµ·ããããšãã調æ»çµæãåºãŠããã
泚ç®ãã¹ãã¯ããã¡ã€ã¶ãŒã»ãã€ãªãã³ããã¯ã®COVIDãžã£ã泚å°ã¯ãã«ããã§ã¯ã»ãšãã©èŠãããªããªã£ãCOVIDã®äºçš®ãXBB.1.5ã®ã¿ãæšçã«ããŠãããšããããšã§ãããçŸåšã®ãšãããåªå¢æ ªã¯EG.5ã§ããã
ã¡ãã£ã¢ã®å§åã«ããããããããžã£ãã»ã¹ããŒã¿ã¹ã®å ¬è¡šãæåŠããå·æå°è ããã
ã¢ã«ããŒã¿å·ã®ãããšã«ã»ã¹ãã¹ã®ããã«ãã¯ã¯ãã³æ¥çš®ããã¹ããŒãã®çŸ©ååã«å察ãããããã®åé¡ã§å éŠéžæãè¡ã£ãã«ããã®å·éŠè³ã®äžã«ã¯ãCOVIDããŒã¹ã¿ãŒããªãªãžãã«ã®COVIDäºé²æ¥çš®ãåãããã©ããããæããã«ããªãè ãããã
å æãã¹ãã¹ã¯èšè å£ã«å¯Ÿããå人çãªCOVIDã¯ã¯ãã³æ¥çš®ã®ç¶æ³ã¯æããã«ããªããšæèšããã
ãå»çäžã®å人çãªæ±ºå®ã¯éå ¬éã«ãããã¹ãã§ããããã®ããã«å»åž«ãã¢ããã€ã¹ãããŠããã®ã ãšæããŸãããšã¹ãã¹ã¯èªã£ãã
å ¬åŒããŒã¿ã«ãããšãã¢ã«ããŒãå·æ°ã®çŽ15.5ïŒ ãCOVIDã®äºé²æ¥çš®ãéžæããŠããã
ããã«å¯Ÿããé£åœã®ããªãã£ãã·ã¥ã»ã³ãã³ãã¢å·ã§ã¯ãå»çåŸäºè ã«COVIDã®æ¥çš®ã矩åä»ããããŠããããã23.1ïŒ ã®æ¥çš®çãšãªã£ãŠããã
ã«ããä¿å¥çã¯ããã¡ã€ã¶ãŒã«ãã瀟ã«2å3800äžæ¬ã®COVID泚å°ãçºæ³šãããã®äžã«ã¯2023幎ãš2024幎åã®3000äžæ¬ãå«ãŸããŠããã
ãã¡ã€ã¶ãŒç€Ÿãšã®å¥çŽã®è©³çްã«ã¯ãæ¿åºããã®äºé²æ¥çš®ã«è²»ãããéé¡ã¯æããã«ãããŠããªãã
COVID泚å°ãåããå€ãã®äººïŒåäŸãå«ãïŒã«å¯äœçšãåŒãèµ·ãããšãã蚌æ ãçžæ¬¡ãã§ããã
äŸãã°ãã«ãããæ ç¹ãšããCorrelation Research in the Public Interestã®ç ç©¶è ãè¡ã£ãæè¿ã®ç ç©¶ã§ã¯ã17ã«åœã§å šæ»å æ»äº¡çã®ããŒã¯ãšCOVID泚å°ããã³ããŒã¹ã¿ãŒã®æ¥éãªæ®åãšã®éã«ãæç¢ºãªå æé¢ä¿ããããããšã倿ããŠããã
LifeSiteNewsã¯æè¿ãCOVID-19ãšãç¹å®ã§ããªãåå ãã«ããæ»äº¡ãããããããå®å šã§å¹æçãªãã¯ã¯ãã³ã®çºå£²åŸã«æ¥å¢ããããšããæ°ãã«çºè¡šãããæ¿åºå ±åæžã瀺ããŠããããšã詳述ããã